Gmo Product Platform (TSE:3695) Other Current Payables: 円4,570 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3695 Gmo Product Platform Inc TSE:3695
71 GF Score
Price 円1,445.00
GF Value 円1,480.31
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Gmo Product Platform Other Current Payables?

Gmo Product Platform TSE:3695 -0.21% 71 Other Current Payables is 円4,570 Mil as of Dec. 2025. GuruFocus rates TSE:3695 with a GF Score™ of 71/100 and a GF Value™ of 円1,480.31 (Fairly Valued). The stock has 3 warning signs investors should review.

Gmo Product Platform's Other Current Payables for the quarter that ended in Dec. 2025 was 円4,570 Mil.

Gmo Product Platform's quarterly Other Current Payables declined from Jun. 2025 (円259 Mil) to Sep. 2025 (円258 Mil) but then increased from Sep. 2025 (円258 Mil) to Dec. 2025 (円4,570 Mil).

Gmo Product Platform's annual Other Current Payables declined from Dec. 2023 (円168 Mil) to Dec. 2024 (円157 Mil) but then increased from Dec. 2024 (円157 Mil) to Dec. 2025 (円4,570 Mil).


Gmo Product Platform Other Current Payables Related Terms


Gmo Product Platform Other Current Payables Historical Data

* Premium members only.

The historical data trend for Gmo Product Platform's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gmo Product Platform Other Current Payables Chart

Gmo Product Platform Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 204.85 234.48 168.47 157.04 4,570.04

Gmo Product Platform Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 195.46 258.73 258.33 4,570.04 4,973.58
TSE:3695
71GF Score
Gmo Product Platform Inc TSE:3695
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gmo Product Platform Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of 円4,570 Mil mean?
Gmo Product Platform (TSE:3695) has a Other Current Payables of 円4,570 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Gmo Product Platform and its competitors.
Is Gmo Product Platform's Other Current Payables too high?
Gmo Product Platform's current Other Current Payables is 円4,570 Mil. Overall, Gmo Product Platform has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Gmo Product Platform's Other Current Payables compare to MSFT and ORCL?
Gmo Product Platform's Other Current Payables of 円4,570 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Software company?
A good Other Current Payables depends on the Software industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Gmo Product Platform and its competitors. Gmo Product Platform's current Other Current Payables is 円4,570 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gmo Product Platform stock overvalued right now?
Based on GuruFocus' analysis, Gmo Product Platform (TSE:3695) is currently considered Fairly Valued. The stock's GF Value™ is 円1,480.31, compared to a current price of 円1,445.00 — trading 2.4% below its estimated fair value. The current Other Current Payables is 円4,570 Mil. Gmo Product Platform's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Gmo Product Platform (TSE:3695), the current Other Current Payables is 円4,570 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gmo Product Platform (TSE:3695) Overvalued in 2026?

Based on GuruFocus' analysis, Gmo Product Platform stock appears to be undervalued. The current stock price of 円1,445.00 is trading 2.4% below its estimated GF Value™ of 円1,480.31. GuruFocus considers Gmo Product Platform to be Fairly Valued.

Key valuation signals for TSE:3695:

  • Other Current Payables: 円4,570 Mil
  • GF Value™: 円1,480.31 vs. price of 円1,445.00 (2.4% below fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the TSE:3695 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gmo Product Platform Business Description

Address Cerulean Tower No. 26, No. 1 Sakuragaoka Town, Shibuya-ku, Tokyo, JPN, 150-8512
Gmo Product Platform Inc offers online payment and business-to-business payment platform services that help startups, tech companies, and SMEs improve payment processing and operational efficiency. The solutions of the company support various business models with digital payment infrastructure and finance-related services.
71GF Score

Get the complete analysis for TSE:3695

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,445.00
Price
円1,480.31
GF Value